Six hundred badly ill Covid-19 clients have gotten blood plasma from recovered patients in a study scientists hope clarify whether the speculative treatment enhances health results and yields other useful data outside the scientific rigor of a standard clinical trial.
The clients are taking part in a nationwide expanded-access program authorized in early April by the federal Fda. Expanded gain access to, also called thoughtful usage, is typically sought by patients with lethal illnesses …
